Do Patient- and Parent-reported Outcomes Measures for Children With Congenital Hand Differences Capture WHO-ICF

Joshua M Adkinson1, Rebecca S Bickham2, Kevin C Chung3

  • 1Division of Plastic Surgery, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA.

Insights

Patient-reported outcome measures (PROMs) for congenital hand differences (CHDs) often fail to capture all health domains and are rarely validated for children. A comprehensive, validated PROM is needed for better assessment of CHD surgical outcomes.

Area of Science:

  • Orthopedics
  • Rehabilitation Medicine
  • Pediatric Surgery

Background:

  • Patient- and parent-reported outcome measures (PROMs) are crucial for evaluating surgery effectiveness in congenital hand differences (CHDs).
  • Existing PROMs' ability to assess self-reported health, including psychosocial aspects, is vital for developing better tools for CHD.
  • However, the alignment of current PROMs with established disability metrics in children with CHD is not well understood.

Purpose of the Study:

  • To determine the number of World Health Organization-International Classification of Functioning, Disability and Health (WHO-ICF) domains covered by PROMs used in CHD surgery studies.
  • To assess the proportion of studies utilizing PROMs specifically validated for pediatric populations with CHD.
  • To identify the extent to which PROMs target patients and/or parents in CHD outcome assessments.

Main Methods:

  • A comprehensive literature review was conducted across MEDLINE, PubMed, and EMBASE from January 1966 to December 2014.
  • Forty-two studies employing PROMs for CHD surgery outcomes were evaluated for WHO-ICF domain coverage and PROM validation status.
  • Commonly used PROMs included the Prosthetic Upper Extremity Functional Index (PUFI) and Disabilities of the Arm, Shoulder, and Hand (DASH) questionnaire.

Main Results:

  • PROMs used in CHD studies covered a mean of only 1.3 WHO-ICF domains.
  • Only two PROMs captured all ICF domains; the PUFI, validated for CHD, was used in just four studies.
  • Patient-reported outcomes were assessed in 13 studies, while only five included both patient and parent reports.

Conclusions:

  • Current PROMs for CHD surgery lack comprehensive evaluation of all WHO-ICF domains and are often not validated for pediatric use.
  • A need exists for a PROM that addresses the biopsychosocial aspects of CHD and is validated in the pediatric population.
  • Developing and implementing such a validated PROM is essential for accurately assessing surgical outcomes in children with CHD.
Abstract

Related Concept Videos